TR200302296T4 - 20 ppm klor iyonundan daha çok ihtiva eden kararlı gabapentin - Google Patents

20 ppm klor iyonundan daha çok ihtiva eden kararlı gabapentin

Info

Publication number
TR200302296T4
TR200302296T4 TR2003/02296T TR200302296T TR200302296T4 TR 200302296 T4 TR200302296 T4 TR 200302296T4 TR 2003/02296 T TR2003/02296 T TR 2003/02296T TR 200302296 T TR200302296 T TR 200302296T TR 200302296 T4 TR200302296 T4 TR 200302296T4
Authority
TR
Turkey
Prior art keywords
chlorine ion
ppm chlorine
stable gabapentin
stable
gabapentin containing
Prior art date
Application number
TR2003/02296T
Other languages
English (en)
Inventor
Singer Claude
Pilarski Gideon
Pesachovich Michael
Schwartz Edi
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22788993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200302296(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of TR200302296T4 publication Critical patent/TR200302296T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Ehemmiyetli ölçüde saf ve kararli gabapentin ihtiva eden farmasötik bilesimler anlatilmistir, bu bilesimlerde, gabapentin, 20 ppm'den büyük miktarlarda, klor gibi bir mineral asitinin bir anyonunu ihtiva etmektedir.
TR2003/02296T 2000-06-16 2001-06-15 20 ppm klor iyonundan daha çok ihtiva eden kararlı gabapentin TR200302296T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21196700P 2000-06-16 2000-06-16

Publications (1)

Publication Number Publication Date
TR200302296T4 true TR200302296T4 (tr) 2004-02-23

Family

ID=22788993

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/02296T TR200302296T4 (tr) 2000-06-16 2001-06-15 20 ppm klor iyonundan daha çok ihtiva eden kararlı gabapentin

Country Status (12)

Country Link
US (1) US6531509B2 (tr)
EP (1) EP1289364B1 (tr)
AT (1) ATE255891T1 (tr)
AU (1) AU2001268426A1 (tr)
CA (1) CA2410867C (tr)
DE (2) DE60101476T2 (tr)
DK (1) DK1289364T3 (tr)
ES (1) ES2193008T3 (tr)
IL (1) IL153398A0 (tr)
PT (1) PT1289364E (tr)
TR (1) TR200302296T4 (tr)
WO (1) WO2001097612A1 (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001266992B8 (en) * 2000-06-16 2005-12-01 Teva Pharmaceutical Industries Ltd. Stable gabapentin having pH within a controlled range
US7056951B2 (en) 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US20030119908A1 (en) * 2001-12-21 2003-06-26 Zambon Group S.P.A. Stable gabapentin compositions
US20040142034A1 (en) * 2002-12-20 2004-07-22 Dynogen Pharmaceuticals, Inc. Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulators
DK1492519T3 (da) * 2003-03-21 2007-03-05 Dynogen Pharmaceuticals Inc Fremgangsmåder til behandling af lidelser i den nedre urinvej ved anvendelse af alfa-2-delta-underenhedscalciumkanalsmodulatorer med glat muskel-modulatorer
WO2005046566A2 (en) * 2003-08-04 2005-05-26 Sun Pharmaceutical Industries Limited Stable gabapentin containing composition
EP1680082A1 (en) * 2003-10-31 2006-07-19 ALZA Corporation Compositions and dosage forms for enhanced absorption of metformin
US20050187295A1 (en) * 2004-02-19 2005-08-25 Surendra Kalyan Processes for the preparation of gabapentin
US20070092565A1 (en) * 2005-10-25 2007-04-26 Pharmascience Inc. Gastric retention drug delivery system
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
CN101462975B (zh) * 2008-08-19 2012-07-25 宁波九胜创新医药科技有限公司 一种高纯度加巴喷丁的制备方法
CN116693410B (zh) * 2023-06-08 2024-06-07 浙江竹子制药有限公司 一种粒径可控的加巴喷丁制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2611690A1 (de) 1976-03-19 1977-09-22 Goedecke Ag Cyclische sulfonyloxyimide
US4894476A (en) * 1988-05-02 1990-01-16 Warner-Lambert Company Gabapentin monohydrate and a process for producing the same
US4960931A (en) 1988-05-02 1990-10-02 Warner-Lambert Company Gabapentin mohohydrate and a process for producing the same
PH27359A (en) 1989-08-25 1993-06-21 Warner Lambert Co Process for cyclic amino acid anticonvulsant compounds
DE3928184A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
US5132451A (en) 1989-08-25 1992-07-21 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
DE3928182A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von gabapentin
DE3928183A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Lactamfreie cyclische aminosaeuren
US5319135A (en) 1989-08-25 1994-06-07 Warner-Lambert Company Process for cyclic amino acid anticonvulsant compounds
US5084479A (en) 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
US5025035A (en) 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
IL119890A (en) * 1996-12-24 2002-03-10 Teva Pharma Gabapentin form iii and preparation of gabapentin form ii
WO1999059572A1 (en) * 1998-05-15 1999-11-25 Warner-Lambert Company Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
BR9910508B1 (pt) * 1998-05-15 2012-01-24 preparações farmacêuticas estabilizadas de derivados de ácido gama-aminobutìrico.
FR2781793B1 (fr) * 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
US6294198B1 (en) 1999-08-24 2001-09-25 Purepac Pharmaceutical Co. Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
US7056951B2 (en) * 2000-09-26 2006-06-06 Mutual Pharmaceutical Co., Inc. Stable solid dosage forms of amino acids and processes for producing same

Also Published As

Publication number Publication date
EP1289364A4 (en) 2003-08-06
ATE255891T1 (de) 2003-12-15
DK1289364T3 (da) 2004-04-13
EP1289364A1 (en) 2003-03-12
DE60101476T2 (de) 2004-05-27
CA2410867A1 (en) 2001-12-27
US6531509B2 (en) 2003-03-11
DE1289364T1 (de) 2003-09-18
IL153398A0 (en) 2003-07-06
PT1289364E (pt) 2004-04-30
WO2001097612A1 (en) 2001-12-27
ES2193008T1 (es) 2003-11-01
ES2193008T3 (es) 2004-07-01
DE60101476D1 (de) 2004-01-22
AU2001268426A1 (en) 2002-01-02
CA2410867C (en) 2003-12-09
US20020061931A1 (en) 2002-05-23
EP1289364B1 (en) 2003-12-10

Similar Documents

Publication Publication Date Title
TR200302296T4 (tr) 20 ppm klor iyonundan daha çok ihtiva eden kararlı gabapentin
ATE289332T1 (de) Silikongel enthaltend salizylsäure
TW200510375A (en) New compounds
IL151313A0 (en) Lipase containing pharmaceutical compositions
PA8548801A1 (es) Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco
SE9802729D0 (sv) Novel Compounds
BR0300709A (pt) Sal de perindopril e as composições farmacêuticas contendo o mesmo
ES2130575T3 (es) Composiciones inmunogenicas mejoradas contra la gastrina 17 humana.
TWI319399B (en) Biguanide and dihydrotriazine derivatives
AU2003294785A1 (en) Hair treatment compositions
TW200509919A (en) Cathepsin S inhibitors
AU2003291972A8 (en) Pharmaceutical compositions comprising insulin and legends of insulin hexamer
CY1108791T1 (el) Φυτοενδυναμωτικο μεσον
DK0937043T3 (da) Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater
WO2002056840A3 (de) Kosmetisches und/oder pharmazeutisches mittel acylierte aminosaüre enthaltend.
DE60128342D1 (de) Verwendung von ozonierten lösungen von tetrasilber tetraoxide
WO2002057246A3 (en) Inhibitors of cruzipain and other cysteine proteases
YU34604A (sh) Oligopeptidi kao inhibitori katepsina s i kompozicije koje ih sadrže
DE60230071D1 (de) Methode für die herstellung von protamin
MXPA03010259A (es) Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos.
DE50107490D1 (de) Stoffgemisch enthaltend bisphenol a
ATE440802T1 (de) Azeotropische zusammensetzungen von iodheptafluorid und fluorwasserstoff
IL159493A0 (en) Pharmaceutical formulation containing an ltb4 antagonist
DE60227536D1 (de) Chemische synthese von solamargin
EA200400650A1 (ru) Трансдермальная фармацевтическая композиция, содержащая аспирин, для лечения кальцификации